Discontinued — last reported Q2 '21
Astera Labs, Inc. Number of Exercisable Options increased by 10538.7% to $285.22M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7388.2%, from $3.81M to $285.22M. This increase may warrant attention — for this metric, lower values are generally preferred.
A high number indicates a higher risk of immediate share dilution if employees choose to exercise their options.
This is the number of stock options held by employees that have met all vesting requirements and are currently eligible...
Standard metric for assessing near-term dilution risk across all public companies.
options_exercisable_number| Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|
| Value | $6.80M | $6.58M | $6.00M | $3.81M | $3.88M | $2.68M | $285.22M |
| QoQ Change | — | -3.2% | -8.8% | -36.6% | +1.9% | -30.9% | >999% |
| YoY Change | — | — | — | -44.0% | -41.0% | -55.3% | >999% |